Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement

Wieneke Vlastra, Jaya Chandrasekhar, Bruno García Del Blanco, Didier Tchétché, Fabio S. de Brito, Marco Barbanti, Ran Kornowski, Azeem Latib, Augusto D'Onofrio, Flavio Ribichini, Jan Baan, Jan G.P. Tijssen, Raul Moreno, Nicolas Dumonteil, Flavio Tarasoutchi, Samantha Sartori, Paola D'Errigo, Giuseppe Tarantini, Mattia Lunardi, Katia OrvinMatteo Pagnesi, Alberto Berenguer, Thomas Modine, George Dangas, Roxana Mehran, Jan J. Piek, Ronak Delewi

Research output: Contribution to journalArticlepeer-review

51 Scopus citations


Background: Transfemoral aortic valve replacement (TAVR) is a guideline-recommended treatment option for patients with severe aortic valve stenosis. Women and men present with different baseline characteristics, which may influence procedural outcomes. Objectives: This study sought to evaluate differences between women and men undergoing transfemoral TAVR across the globe during the last decade. Methods: The CENTER (Cerebrovascular EveNts in patients undergoing TranscathetER aortic valve implantation with balloon-expandable valves versus self-expandable valves)-collaboration was a global patient level dataset of patients undergoing transfemoral TAVR (N = 12,381) from 2007 to 2018. In this retrospective analysis, the study examined differences in baseline patient characteristics, 30-day stroke and mortality, and in-hospital outcomes between female and male patients. The study also assessed for temporal changes in outcomes and predictors for mortality per sex. Results: We included 58% (n = 7,120) female and 42% (n = 5,261) male patients. Women had higher prevalence of hypertension and glomerular filtration rate <30 ml/min/1.73 m2 but lower prevalence of all other traditional cardiovascular comorbidities. Both sexes had similar rates of 30-day stroke (2.3% vs. 2.5%; p = 0.53) and mortality (5.9% vs. 5.5%; p = 0.17). In contrast, women had a 50% higher risk of life-threatening or major bleeding (6.7% vs. 4.4%; p < 0.01). Over the study period, mortality rates decreased to a greater extent in men than in women (60% vs. 50% reduction; both p < 0.001), with no reductions in stroke rates over time. Conclusions: In this global collaboration, women and men had similar rates of 30-day mortality and stroke. However, women had higher rates of procedural life-threatening or major bleeding after TAVR. Between 2007 and 2018, mortality rates decreased to a greater extent in men than in women.

Original languageEnglish (US)
Pages (from-to)2758-2767
Number of pages10
JournalJournal of the American College of Cardiology
Issue number22
StatePublished - Dec 3 2019


  • outcome differences over time
  • predictors of 30-day mortality
  • sex differences
  • transfemoral aortic valve implantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement'. Together they form a unique fingerprint.

Cite this